DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
CardioDx - Bringing molecular diagnostics into the cardiovascular arena
News | 03. 01. 2010
CardioDx
CardioDx is one of several molecular diagnostics companies founded by a well-known trio of West Coast VCs to be fast finding itself in the spotlight.
